Source: Golden Helix Blog

Golden Helix Blog Bringing Phasing Information from Long-Read Data into a Trio Analysis

Golden Helix customers continue to push the boundaries of genomic research and clinical applications, leveraging VarSeq to analyze complex genetic data and uncover previously uncatalogued variants. With advancements in long-read sequencing and our recent updates to the VarSeq software, clinicians can now harness phasing information to distinguish between inherited and novel mutations in a Trio analysis with unprecedented accuracy. In... Read more »The post Bringing Phasing Information from Long-Read Data into a Trio Analysis appeared first on The Golden Helix Blog.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andreas Scherer's photo - President & CEO of Golden Helix

President & CEO

Andreas Scherer

CEO Approval Rating

86/100

Read more